Affinity Asset Advisors, LLC
- SEC CIK
- 0001773195
- 最新申報
- 2026/8/13
2022 年第 4 季持倉
持倉截至 2022/12/31，2023/2/13 申報。只含多頭部位，變化是跟 2022 年第 3 季比股數。
- 持股檔數
- 54
- 較 2022 年第 3 季 +7
- 總值
- $2.18 億
- 較 2022 年第 3 季 +$125.3 萬 (+0.6%)
| 證券 | 類別 | 股數 | 市值 | 佔組合 % | 股數變化 | 動作 | 紀錄 |
|---|---|---|---|---|---|---|---|
| KDNYChinook Therapeutics, Inc. | COM | 818,035 | $2,143 萬 | 9.8% | +4,037+0.5% | 加碼 | 歷史 |
| MDGLMadrigal Pharmaceuticals, Inc. | COM | 70,000 | $2,032 萬 | 9.3% | −30,000−30.0% | 減碼 | 歷史 |
| ESTAEstablishment Labs Holdings Inc. | COM | 190,767 | $1,252 萬 | 5.7% | −135,901−41.6% | 減碼 | 歷史 |
| ASNDAscendis Pharma A/S | SPONSORED ADR | 70,997 | $867.1 萬 | 4.0% | −29,003−29.0% | 減碼 | 歷史 |
| BMRNBiomarin Pharmaceutical Inc | COM | 80,000 | $827.9 萬 | 3.8% | +80,000 | 新進 | 歷史 |
| RXDXPrometheus Biosciences, Inc. | COM | 75,000 | $825.0 萬 | 3.8% | +50,000+200.0% | 加碼 | 歷史 |
| VRNAVerona Pharma plc | SPONSORED ADS | 312,498 | $816.6 萬 | 3.7% | −37,502−10.7% | 減碼 | 歷史 |
| VTYXVentyx Biosciences, Inc. | COM | 240,623 | $789.0 萬 | 3.6% | +70,623+41.5% | 加碼 | 歷史 |
| MORFMorphic Holding, Inc. | COM | 280,921 | $751.5 萬 | 3.4% | +134,430+91.8% | 加碼 | 歷史 |
| ACLXArcellx, Inc. | COMMON STOCK | 240,143 | $744.0 萬 | 3.4% | +30,005+14.3% | 加碼 | 歷史 |
| CBAYCymaBay Therapeutics, Inc. | COM | 1,143,531 | $717.0 萬 | 3.3% | −146,980−11.4% | 減碼 | 歷史 |
| ATXSAstria Therapeutics, Inc. | COM | 472,482 | $703.5 萬 | 3.2% | +72,439+18.1% | 加碼 | 歷史 |
| CERECerevel Therapeutics Holdings, Inc. | COM | 215,000 | $678.1 萬 | 3.1% | +215,000 | 新進 | 歷史 |
| NARIInari Medical, Inc. | Stock | 90,000 | $572.0 萬 | 2.6% | −30,000−25.0% | 減碼 | 歷史 |
| HZNPHorizon Therapeutics Public Ltd Co | SHS | 45,000 | $512.1 萬 | 2.3% | +45,000 | 新進 | 歷史 |
| RCKTRocket Pharmaceuticals, Inc. | COM | 258,115 | $505.1 萬 | 2.3% | −9,679−3.6% | 減碼 | 歷史 |
| CLDXCelldex Therapeutics, Inc. | COM NEW | 110,000 | $490.3 萬 | 2.2% | +30,000+37.5% | 加碼 | 歷史 |
| Bellus Health Inc New07987C204 | COM NEW | 573,678 | $471.6 萬 | 2.2% | +100,081+21.1% | 加碼 | – |
| AZNAstraZeneca PLC | SPONSORED ADR | 60,000 | $406.8 萬 | 1.9% | −90,000−60.0% | 減碼 | 歷史 |
| CYTKCytokinetics Inc | COM NEW | 87,601 | $401.4 萬 | 1.8% | +22,601+34.8% | 加碼 | 歷史 |
| BridgeBio Pharma, Inc.10806XAD4 | NOTE 2.250% 2/0 | – | $389.5 萬 | 1.8% | – | – | – |
| BridgeBio Pharma, Inc.10806XAB8 | NOTE 2.500% 3/1 | – | $341.0 萬 | 1.6% | – | – | – |
| KURAKura Oncology, Inc. | COM | 268,747 | $333.5 萬 | 1.5% | −407,006−60.2% | 減碼 | 歷史 |
| VKTXViking Therapeutics, Inc. | COM | 350,000 | $329.0 萬 | 1.5% | +100,000+40.0% | 加碼 | 歷史 |
| LNTHLantheus Holdings, Inc. | Stock | 60,630 | $309.0 萬 | 1.4% | −69,370−53.4% | 減碼 | 歷史 |
| PCVXVaxcyte, Inc. | COM | 60,000 | $287.7 萬 | 1.3% | +60,000 | 新進 | 歷史 |
| SNDXSyndax Pharmaceuticals Inc | COM | 100,000 | $254.5 萬 | 1.2% | +100,000 | 新進 | 歷史 |
| IOVAIovance Biotherapeutics, Inc. | COM | 375,000 | $239.6 萬 | 1.1% | +375,000 | 新進 | 歷史 |
| KPTIKaryopharm Therapeutics Inc. | COM | 661,264 | $224.8 萬 | 1.0% | +661,264 | 新進 | 歷史 |
| COGTCogent Biosciences, Inc. | COM | 193,064 | $223.2 萬 | 1.0% | +38,977+25.3% | 加碼 | 歷史 |
| PNTPOINT Biopharma Global Inc. | COM | 303,218 | $221.0 萬 | 1.0% | −443,358−59.4% | 減碼 | 歷史 |
| XENEXenon Pharmaceuticals Inc. | COM | 50,000 | $197.2 萬 | 0.9% | +50,000 | 新進 | 歷史 |
| ARGXArgenx SE | SPONSORED ADR | 5,000 | $189.4 萬 | 0.9% | +5,000 | 新進 | 歷史 |
| ALPNAlpine Immune Sciences, Inc. | COM | 247,891 | $182.2 萬 | 0.8% | +137,891+125.4% | 加碼 | 歷史 |
| VINCVincerx Pharma, Inc. | COM NEW | 1,492,771 | $152.3 萬 | 0.7% | 00.0% | 不變 | 歷史 |
| Intrexon Corp46122TAA0 | NOTE 3.500% 7/0 | – | $148.8 萬 | 0.7% | – | – | – |
| CNTACentessa Pharmaceuticals plc | SPONSORED ADS | 460,328 | $142.7 萬 | 0.7% | +217,811+89.8% | 加碼 | 歷史 |
| Esperion Therapeutics Inc Ne29664WAB1 | NOTE 4.000%11/1 | – | $136.4 萬 | 0.6% | – | 新進 | – |
| KALVKalVista Pharmaceuticals, Inc. | COM | 188,292 | $127.3 萬 | 0.6% | +91,974+95.5% | 加碼 | 歷史 |
| BCABBioAtla, Inc. | COM | 150,000 | $123.8 萬 | 0.6% | +150,000 | 新進 | 歷史 |
| DYNDyne Therapeutics, Inc. | COM | 92,170 | $106.8 萬 | 0.5% | +92,170 | 新進 | 歷史 |
| LIANYLianBio | SPONSORED ADS | 650,000 | $106.6 萬 | 0.5% | +100,000+18.2% | 加碼 | 歷史 |
| NRIXNurix Therapeutics, Inc. | COM | 80,000 | $87.8 萬 | 0.4% | +80,000 | 新進 | 歷史 |
| MIRMMirum Pharmaceuticals, Inc. | COM | 40,000 | $78.0 萬 | 0.4% | +40,000 | 新進 | 歷史 |
| FHTXFoghorn Therapeutics Inc. | COM | 109,991 | $70.2 萬 | 0.3% | +109,991 | 新進 | 歷史 |
| SGENSeagen Inc. | COM | 5,000 | $64.3 萬 | 0.3% | +5,000 | 新進 | 歷史 |
| CNTXContext Therapeutics Inc. | COM | 883,654 | $58.4 萬 | 0.3% | 00.0% | 不變 | 歷史 |
| INZYInozyme Pharma, Inc. | COM | 500,000 | $52.5 萬 | 0.2% | +500,000 | 新進 | 歷史 |
| NUVBNuvation Bio Inc. | COM CL A | 250,000 | $48.0 萬 | 0.2% | +250,000 | 新進 | 歷史 |
| Immatics N.V.N44445117 | *W EXP 07/01/202 | 187,204 | $47.0 萬 | 0.2% | 00.0% | 不變 | – |
| MISTMilestone Pharmaceuticals Inc. | COM | 100,000 | $39.6 萬 | 0.2% | +100,000 | 新進 | 歷史 |
| SCLXWScilex Holding Co | *W EXP 11/10/202 | 18,099 | $3,419 | <0.1% | +18,099 | 新進 | 歷史 |
| Medicus Sciences AcquisitionG5960S124 | *W EXP 02/12/202 | 33,333 | $2,933 | <0.1% | 00.0% | 不變 | – |
| SCLXScilex Holding Co | COM | 463 | $1,847 | <0.1% | +463 | 新進 | 歷史 |
選擇權（8 檔）
同一份申報裡的賣權（put）與買權（call）。金額是標的股票的市值，也就是 13F 申報的數字。
| 證券 | 類別 | 賣權 | 買權 |
|---|---|---|---|
| BMYBristol Myers Squibb Co | Stock | $1,259 萬 | – |
| MRNAModerna, Inc. | Stock | $538.9 萬 | – |
| AMGNAmgen Inc | Stock | $525.3 萬 | – |
| GERNGeron Corp | COM | $255.7 萬 | $202.6 萬 |
| VRNAVerona Pharma plc | SPONSORED ADS | – | $274.4 萬 |
| VKTXViking Therapeutics, Inc. | COM | – | $235.0 萬 |
| NVAXNovavax Inc | COM NEW | $205.6 萬 | – |
| NVCRNovoCure Ltd | ORD SHS | – | $183.4 萬 |
2022 年第 3 季之後清倉（14 檔）
2022 年第 3 季季末還持有、這份申報已經沒有的部位。
| 證券 | 類別 | 2022 年第 3 季股數 | 2022 年第 3 季市值 | 2022 年第 3 季佔組合 % | 紀錄 |
|---|---|---|---|---|---|
| GBTGlobal Blood Therapeutics, Inc. | COM | 190,000 | $1,294 萬 | 6.0% | 歷史 |
| SNYSanofi | SPONSORED ADR | 300,000 | $1,141 萬 | 5.3% | 歷史 |
| Retrophin Inc761299AB2 | NOTE 2.500% 9/1 | – | $1,113 萬 | 5.1% | – |
| Nanostring Technologies Inc63009RAD1 | NOTE 2.625% 5/0 | – | $854.4 萬 | 3.9% | – |
| SWTXSpringWorks Therapeutics, Inc. | COM | 175,000 | $499.3 萬 | 2.3% | 歷史 |
| ZNTLZentalis Pharmaceuticals, Inc. | COM | 170,000 | $368.2 萬 | 1.7% | 歷史 |
| ARYEARYA Sciences Acquisition Corp V | CLASS A ORD SHS | 352,500 | $346.5 萬 | 1.6% | 歷史 |
| GSKGSK plc | ADR | 75,000 | $220.7 萬 | 1.0% | 歷史 |
| ACRSAclaris Therapeutics, Inc. | COM | 136,434 | $214.7 萬 | 1.0% | 歷史 |
| NAUTNautilus Biotechnology, Inc. | COM | 372,476 | $79.0 萬 | 0.4% | 歷史 |
| RCORRenovacor, Inc. | COM | 199,490 | $50.3 萬 | 0.2% | 歷史 |
| TNGXTango Therapeutics, Inc. | COM | 81,982 | $29.7 萬 | 0.1% | 歷史 |
| Vickers Vantage Corp IG9440B115 | *W EXP 09/15/202 | 100,000 | $1.70 萬 | <0.1% | – |
| Renovacor, Inc.75989E114 | *W EXP 99/99/999 | 75,000 | $6,000 | <0.1% | – |